Science Corporation implants its vision-restoring chip in its first Stargardt disease patient

Science Corporation CEO Max Hodak announced that the company has implanted its vision-restoring chip, PRIMA, into its first patient with Stargardt disease, an inherited eye disease that gradually destroys central vision. Hodak, the former president and co-founder of Neuralink, the brain implant company, explained on stage at TechCrunch Disrupt how... [Nội dung đầy đủ và hình ảnh đã được ẩn đối với công cụ tự động]